Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stevens - Johnson Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01178242
What this trial is testing

Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome.

Who this might be right for
SymblepharonDry EyeOcular Surface Disease+1 more
Federal University of São Paulo 19
Not applicableStudy completedNCT02945176
What this trial is testing

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Who this might be right for
Graft vs Host DiseaseCongenital AniridiaChemical Burns+2 more
Implandata Ophthalmic Products GmbH 13
Not applicableWithdrawnNCT02795143
What this trial is testing

Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study

Who this might be right for
Toxic Epidermal Necrolysis
Massachusetts General Hospital
Not applicableEnded earlyNCT04313725
What this trial is testing

Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease

Who this might be right for
Stevens-Johnson SyndromeGraft Versus Host Disease in EyeSjogren's Syndrome+1 more
Tangible Science 28
Not applicableUnknownNCT05145959
What this trial is testing

Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal NecrolysesOcular Surface Disease+3 more
Massachusetts Eye and Ear Infirmary 30
Large-scale testing (Phase 3)Ended earlyNCT00295776
What this trial is testing

Lamictal in the Treatment of Post-Herpetic Neuralgia

Who this might be right for
Neuralgia, Postherpetic
George Washington University
Not applicableUnknownNCT02574988
What this trial is testing

Severe Cutaneous Adverse Reactions in Thailand

Who this might be right for
Steven-Johnson SyndromeToxic Epidermal NecrolysisDrug Reaction With Eosinophilia and Systemic Symptoms+2 more
Chulalongkorn University 200
Testing effectiveness (Phase 2)Ended earlyNCT02037347
What this trial is testing

Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal NecrolysisStevens-Johnson Syndrome
Brett King 1
Large-scale testing (Phase 3)Study completedNCT00346450
What this trial is testing

Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation

Who this might be right for
PterygiumOcular Surface DiseaseStevens Johnson Syndrome+1 more
Singapore National Eye Centre 80
Not applicableUnknownNCT03184597
What this trial is testing

HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions

Who this might be right for
EpilepsyNeuropathyPsychiatric Illness+1 more
Second Affiliated Hospital of Guangzhou Medical University 4,000
Not applicableUnknownNCT03046914
What this trial is testing

HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction

Who this might be right for
Stevens-Johnson SyndromeKidney Failure, Chronic
Seoul National University Hospital 600
Testing effectiveness (Phase 2)UnknownNCT05520086
What this trial is testing

Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.

Who this might be right for
Chronic ConjunctivitisStevens-Johnson SyndromeLyell Syndrome+1 more
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07369622
What this trial is testing

HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness

Who this might be right for
Gout Initiating Urate-loweringUrate-lowering TherapyGout ArthritisGout and Hyperuricemia
Haiphong University of Medicine and Pharmacy 228
Not applicableUnknownNCT05284929
What this trial is testing

Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population

Who this might be right for
PemphigusBullous PemphigoidStevens-Johnson Syndrome+1 more
Sechenov University 120
Testing effectiveness (Phase 2)WithdrawnNCT01256489
What this trial is testing

Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)

Who this might be right for
Stevens-Johnson SyndromeCorneal Blindness
Massachusetts Eye and Ear Infirmary
Not applicableStudy completedNCT05320653
What this trial is testing

Nutritional and Metabolic Management of Toxidermia Patients Requiring Intensive Care (TEN Metabolism)

Who this might be right for
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
Centre Hospitalier Universitaire Vaudois 35
Testing effectiveness (Phase 2)WithdrawnNCT02319616
What this trial is testing

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal Necrolysis
University of California, Davis
Post-approval studies (Phase 4)Study completedNCT01488396
What this trial is testing

Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye

Who this might be right for
Stevens-Johnson Syndrome
Mahidol University 31
Not applicableWithdrawnNCT03585946
What this trial is testing

Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal NecrolysisDrug Reaction
Massachusetts General Hospital
Large-scale testing (Phase 3)Study completedNCT01696500
What this trial is testing

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis
Nihon Pharmaceutical Co., Ltd 10
Next Page